Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDistrib. Fin. Regulatory News (DFCH)

Share Price Information for Distrib. Fin. (DFCH)

Share Price is delayed by 15 minutes
Get Live Data
54.50    0.50 (0.93%)
Bid:
54.00
Ask:
55.00
Spread: 1.00 (1.852%)
Market Cap: £89.43m
DFCH Live PriceLast checked at - London Stock Exchange

Intraday Distrib. Fin. Share Chart

Trading Update

4 Jul 2024 07:00

RNS Number : 0669V
Distribution Finance Cap. Hldgs PLC
04 July 2024
Β 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation (EU no. 596/2014) as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 (as amended from time to time).

Β 

4 July 2024

Β 

Distribution Finance Capital Holdings plc

("DF Capital" or the "Company" together with its subsidiaries the "Group")

Β 

Β 

Trading update for six months ended 30 June 2024

Β 

Continued momentum with full year results now expected to be significantly ahead of market expectations

Β 

Distribution Finance Capital Holdings plc, a specialist bank providing working capital solutions to dealers and manufacturers across the UK, is pleased to provide a trading update for the six months ended 30 June 2024.

Β· The Group has continued to see strong momentum during the period with new loan origination exceeding a record Β£709m, up c17% on the prior year (H1 2023: Β£607m).

Β· The Group's loan book at 30 June 2024 reached Β£600m, up c16% on the prior year (H1 2023: Β£519m) and which is in line with seasonal expectations. Whilst new loan origination remains strong, the Group has seen a normalisation of the seasonality in loan repayments during the year (i.e. an acceleration of dealer sales during the period March to September), a first since the onset of the global pandemic.Β 

Β· The Group now supports 90 manufacturer partners and its dealer customers total 1,250 on a net basis (H1 2023: 1,152) having added 165 new dealers in the period. Credit lines reached a record cΒ£1.1bn, up c21% on prior year (30 June 2023: Β£926m).

Β· Average stock days, which measures the average age of loans outstanding, remains well within sector tolerances, extending marginally on a portfolio basis to 149 days (31 December 2023: 148 days) at the period end.

Β· In spite of the challenges of the macro-economic and higher interest rate environment, the Group's overdue accounts have continued to perform well and ahead of expectations through the period. 20 dealers (H1 2023: 29), including 10 cases in legal recovery, had arrears one day past due, representing c1.6% (H1 2023: c 2.5%) of the Group's dealer base. The Group's total arrears balance represented c0.5% (H1 2023: 2.5%) of its entire loan book.

In light of the strong performance during the six month period, the Group's underlying trading performance is expected to be ahead of market expectations for the full year, driven by stronger net interest income, lower impairments and loss provisions and stronger cost control.

Additionally, having prudently written off approximately Β£10m in respect of the RoyaleLife balance, the Group has continued in its pursuit of the fullest possible level of financial recovery. The Group is pleased to announce, having now exhausted all opportunities, that it has now recovered assets and cash and agreed legal settlement with related parties to the aggregate sum of cΒ£4.7m, of which cΒ£1.7m is expected to be recognised in H1 2024. The remaining Β£3m of this settlement amount is subject to the sale of assets (including property) by a third party and it is therefore anticipated that this will be recovered in the financial year ending 31 December 2025.

Given the Company's strong underlying operational and financial momentum and the financial recovery in relation to RoyaleLife, the Group expects to report a pre-tax profit for the six month ended 30 June 2024 of no less than Β£9.0m, which is significantly ahead of its expectations and more than the entire FY23 outturn of Β£4.6m. Accordingly, the Group expects its full year outturn for 2024 to significantly exceed market expectations.

The Group has also continued with the organic build of a hire purchase lending capability, which unlocks entry into significantly larger addressable markets than the Company's current offering, supporting the sales of its existing dealers and manufacturers to end-user consumers. The Group does not expect to start lending in this market adjacency until 2025, which is subject to regulatory approval.

The Company expects to provide a fuller update when it announces its interim results for the six months ended 30 June 2024 in September 2024.

Β 

Carl D'Ammassa, Chief Executive, commented: "2024 has started exceptionally well, with strong operational and commercial execution as well as portfolio management and control. Our products and services clearly resonate with our customers and seeing continued record new loan origination is a testament to the entire team's focus on providing high quality service and the deep relationships we have with our dealer and manufacturer partners. I am pleased with the Group's trading performance so far this year and this gives us confidence for the rest of the year. It is pleasing to see our efforts in working through the RoyaleLife situation deliver significant recoveries and upside potential to our financial expectations."

Β 

The person responsible for arranging the release of this announcement on behalf of the Company is Karen D'Souza (Company Secretary).

Β 

For further information contact:

Distribution Finance Capital Holdings plc

Carl D'Ammassa - Chief Executive Officer

+44 (0) 161 413 3391

Kam Bansil - Head of Investor Relations

+44 (0) 7779 229508

http://www.dfcapital-investors.com

Β 

Panmure Liberum Limited (Nomad and Broker)

+44 (0) 203 100 2000

Chris Clarke

William King

Anake Singh

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFFFIIDLIVIIS
Date   Source Headline
21st May 202611:34 amRNSResult of AGM
5th May 20263:42 pmRNSHolding(s) in Company
24th Apr 202612:16 pmRNSNotice of AGM
13th Apr 20263:47 pmRNSBoard change
8th Apr 20267:00 amRNSQ1 Trading Update
23rd Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSNotice of Full Year Results and Presentations
27th Jan 20264:08 pmRNSDirector/PDMR Shareholding
22nd Jan 20264:21 pmRNSHolding(s) in Company
15th Jan 20263:37 pmRNSDirector/PDMR Shareholding
15th Jan 20267:00 amRNSFull Year Trading Update
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
11th Dec 20254:34 pmRNSDirector/PDMR Shareholding
1st Dec 20255:14 pmRNSHolding(s) in Company
19th Nov 20257:00 amRNSChange of Registered Office
18th Nov 20253:54 pmRNSHolding(s) in Company
18th Nov 20251:13 pmRNSHolding(s) in Company
13th Nov 20255:05 pmRNSHolding(s) in Company
12th Nov 20255:30 pmRNSHolding(s) in Company
6th Nov 20253:52 pmRNSHolding(s) in Company
4th Nov 20253:44 pmRNSHolding(s) in Company
3rd Nov 20254:44 pmRNSHolding(s) in Company
3rd Nov 202512:28 pmRNSHolding(s) in Company
30th Oct 20254:55 pmRNSHolding(s) in Company
28th Oct 20254:48 pmRNSHolding(s) in Company
28th Oct 20254:43 pmRNSHolding(s) in Company
27th Oct 20253:25 pmRNSHolding(s) in Company
24th Oct 202510:52 amRNSHolding(s) in Company
21st Oct 20254:50 pmRNSHolding(s) in Company
17th Oct 20254:58 pmRNSHolding(s) in Company
16th Oct 202510:31 amRNSHolding(s) in Company
14th Oct 20253:55 pmRNSHolding(s) in Company
13th Oct 20253:11 pmRNSHolding(s) in Company
13th Oct 202510:26 amRNSHolding(s) in Company
10th Oct 202512:23 pmRNSHolding(s) in Company
9th Oct 20257:00 amRNSQ3 Trading Update
7th Oct 20259:49 amRNSHolding(s) in Company
6th Oct 20259:09 amRNSHolding(s) in Company
6th Oct 20259:09 amRNSHolding(s) in Company
2nd Oct 20254:33 pmRNSHolding(s) in Company
30th Sep 20258:50 amRNSHolding(s) in Company
29th Sep 20252:40 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSTransfer of Treasury Shares & Total Voting Rights
25th Sep 202511:11 amRNSHolding(s) in Company
18th Sep 20254:57 pmRNSHolding(s) in Company
17th Sep 20254:18 pmRNSHolding(s) in Company
17th Sep 20257:00 amRNSNon-Executive Director Appointment
15th Sep 20255:45 pmRNSHolding(s) in Company
12th Sep 20257:40 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.